Video resources

Prof Richard Holt and Nicki Milne

The evolving landscape: Type 2 diabetes management and diabetes-related mental health

Play the summary video

Play the full video

Downloadable resources

Download document Opens in new tab

Smiling muslim woman enjoying iftar during ramadan

Download document Opens in new tab

A woman being comforted by a healthcare professional

Download document Opens in new tab

Download document Opens in new tab

View related resources

Know more

Know more

Linagliptin is indicated in adults with type 2 diabetes mellitus as an adjunct to diet and exercise to improve glycaemic control as:

monotherapy when metformin is inappropriate due to intolerance, or contraindicated due to renal impairment
in combination with other medicinal products for the treatment of diabetes, including insulin, when these do not provide adequate glycaemic control

PC-GB-112449 | May 2026

Reporting adverse events

Adverse events should be reported. Reporting forms and information can be found at www.mhra.gov.uk/yellowcard. Adverse events should also be reported to Boehringer Ingelheim Drug Safety on 0800 328 1627 (freephone).

Please be aware that this website contains promotional information about Boehringer Ingelheim medicines and services. Some of this may not be directly relevant to your scope of practice and it is your own decision whether you choose to view this information.

Healthcare professional resources

Video resources

The evolving landscape: Type 2 diabetes management and diabetes-related mental health

Downloadable resources

Managing type 2 diabetes and diabetes-related mental health

A case-based approach to the management of type 2 diabetes during Ramadan

The management of type 2 diabetes in adults with complex comorbidities

Addressing treatment non-adherence in adults with type 2 diabetes

View related resources

Patient resources

Reporting adverse events